
Olfactory dysfunction (OD) in people with cystic fibrosis (PwCF) is linked to worse quality of life (QOL) and eating-related impairments. In a study of 59 PwCF, anosmia correlated with worse sinus CT scores and a 2.38x higher risk of eating-related QOL decline. Highly effective modulator therapy (HEMT) improved CT scores but not OD rates. OD severity was significantly associated with increased CRS burden and impaired daily life.
Like
Save
Share